Blog - Page 3174 of 5683

MondayJul 02, 2012 4:01 pm

Cytomedix, Inc. (CMXI) and Possible Partner Extend Exclusivity and Enter Distribution Negotiations

Cytomedix, a regenerative therapies company focused on commercializing and developing innovative platelet and adult stem cell technologies for wound and tissue repair, today said it has extended the exclusivity period regarding an agreement with a Top 20 global pharmaceutical company to negotiate distribution of the AutoloGel System in the United States. The parties have agreed to extend the exclusivity period until August 30, 2012, and are now in discussions to negotiate the details of a distribution agreement. The companies expect to commence sales when the agreement is finalized, on or before the exclusivity date. The distribution agreement is expected to…

MondayJul 02, 2012 3:56 pm

USA Recycling Industries, Inc. (USRI) Grows Through Company Owned and Partnership Recycling Centers

USA Recycling Industries is a recyclable waste collection and disposal company serving commercial and industrial customers throughout North America, operating via multiple company-owned and partnership recycling centers. The company is focused largely on the automotive service center industry, collecting scrap metal, oil filters, oils and lubricants, tires, and batteries, processing the recyclable materials to end-user-consumers. The company has a strong franchising system, under Recycling Franchisors, Inc., with the franchise centers doing business under the name USA Recycling. A USA Recycling specialty service center collects and sells automotive waste materials from underserved sectors within the automotive service center industry, in addition…

MondayJul 02, 2012 12:41 pm

Tegal Corp. (TGAL) Appoints James Karis as Co-CEO of the Company

Tegal has been in business for 40 years, with a current focus on emerging technologies in the healthcare sector. The company's process and equipment know-how has been incorporated into devices fabricated by some of the world's leading semiconductor and microelectromechanical systems (MEMS) companies, including its one-time parent firm, Motorola. The company announced today that it expects to appoint James Karis as Co-CEO of Tegal and also a director of the firm. The appointment will effective upon completion of the deal to acquire CollabRx Inc., where Mr. Karis serves as CEO and director. CollabRx is a privately-held technology company in the…

MondayJul 02, 2012 12:39 pm

Comstock Mining Inc. (LODE) Finishes Heap Leach Facility and Pond, Preps Lucerne West Mine for Production

Comstock Mining has amassed a considerable footprint of contiguous gold and silver acreage in Nevada's legendary Comstock District and was pleased to report today that completion of the sizeable Heap Leach facility (now five cells with all the setup done for another two cells) will amply support accrued ore production from the Lucerne West Mine. In addition, considerable progress has been made to Lucerne, including site prep, ramp, and road construction. The three old cells of the heap leach have been leveled and reworked for stacking of material (up to the permit height of 105 feet) by the company's new…

MondayJul 02, 2012 11:10 am

Skinny Nutritional Corp. (SKNY) Receives $15,000,000 Financing to Accelerate Growth Initiatives

Skinny Nutritional, the maker of Skinny Water® and a leader in the zero-calorie enhanced water category, announced this morning that it has secured financing to drive a national expansion strategy. Trim Capital LLC has agreed to a financing transaction involving the issuance of $9,000,000 of preferred and common stock and a $6,000,000 senior secured credit facility. At the initial closing, Skinny Nutritional sold a $1,000,000 senior secured bridge note. "The investment Trim Capital is making in Skinny Water will give the Company the capital to execute its growth plan. Having access to this capital will allow us to accelerate our…

MondayJul 02, 2012 10:17 am

Anthera Pharmaceuticals, Inc. (ANTH) Video Chart for Monday, June 2, 2012

A look at ANTH's 15-minute charts, combined with the daily charts, shows that the stock could be aligning for a "dead cat bounce." Technical traders will be looking for a new support level to be established and any upward movement to meet resistance near $0.80, where the stock still has a short-term, open gap that is unfilled presently. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

MondayJul 02, 2012 8:23 am

Vidable, Inc. (VIBE) Spammed Aggressively over Weekend

We have observed an influx of emails spamming Vidable from various free email accounts over the weekend. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue. Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics page, visit…

FridayJun 29, 2012 4:59 pm

Seeking Alpha Article Features International Stem Cell Corp. (ISCO), Touts Stem Cell Technology’s Bright Future

In an article published earlier today featuring key players in the stem cell industry, International Stem Cell Corp. was labeled as being possibly "the most promising" as the company has developed a breakthrough technology that provides pluripotent stem cells without using viable human embryos and without the issues associated with induced pluripotent stem cells or adult stem cells. Based upon unfertilized human eggs, ISCO's technology also allows superior immune-matching capabilities. The idea behind stem cells has in fact been around for a very long time. Ever since the invention of the microscope and the development of cell theory, scientists have…

FridayJun 29, 2012 4:50 pm

Ohr Pharmaceutical, Inc. (OHRP) Announces $2.91M Financing through Exercised Series H Warrants

Ohr Pharmaceutical today announced that its existing shareholders have exercised 5,299,022 Series H warrants at $0.55 per warrant, resulting in net proceeds of $2.91 million. The company offered shareholders 0.6 replacement warrants for every Series H warrant exercised, resulting in the aggregate issuance of 3,179,410 warrants exercisable at $1.20 for a five-year period; 95 percent of the outstanding Series H warrants were exercised in this transaction. Ohr Pharmaceutical said it plans on using the proceeds for general corporate purposes, as well as to advance the clinical development of its compounds: Squalamine eye drops for the treatment of wet-AMD and neovascular…

FridayJun 29, 2012 3:41 pm

CytoSorbents Corp. (CTSO) Blood Purification System Data Featured at Western Thoracic Surgical Association

CytoSorbents is a therapeutic device company using blood purification to modulate the immune system, reduce severe inflammation, and prevent or treat organ failure caused by life-threatening illnesses. The company today announced the presentation of data from its research collaboration at the Annual Meeting of the Western Thoracic Surgical Association in Hawaii, being held today. Dr. David Rabkin, assistant professor of Surgery, Division of Cardiothoracic Surgery at the University of Washington Medical Center in Seattle, Wash., will present the potential future use of CytoSorb® blood purification system to protect the viability of organs donated by patients who are officially dead from…

Site Search

Company Search